Roquefort Therapeutics plc (LON:ROQ)
London · Delayed Price · Currency is GBP · Price in GBX 0.9750
-0.0250 (-2.50%)
Mar 26, 2026, 1:55 PM GMT
Roquefort Therapeutics Market Cap
Roquefort Therapeutics has a market cap or net worth of 1.64 million as of March 26, 2026. Its market cap has decreased by -24.61% in one year.
Market Cap
1.64M
Enterprise Value
1.84M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.98
Market Cap Chart
Since March 22, 2021, Roquefort Therapeutics's market cap has decreased from 2.19M to 1.64M, a decrease of -25.14%. That is a compound annual growth rate of -5.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 1.64M | -20.00% |
| Dec 31, 2025 | 2.05M | -62.77% |
| Dec 31, 2024 | 5.50M | -41.29% |
| Dec 29, 2023 | 9.36M | 9.43% |
| Dec 30, 2022 | 8.56M | 13.33% |
| Dec 31, 2021 | 7.55M | 245.20% |
| Mar 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cizzle Biotechnology Holdings | 8.92M |
| Futura Medical | 7.39M |
| IXICO | 7.23M |
| CRISM Therapeutics | 5.82M |
| OptiBiotix Health | 5.42M |
| Nuformix | 4.44M |
| Theracryf | 4.41M |
| Thalia Therapeutics | 3.75M |